中药调控肠道菌群降脂减肥作用机制研究
The Therapeutic Mechanisms of Gut Microbiota Regulated by Traditional Chinese Medicines for Obesity Epidemic

DOI: 10.12677/PI.2021.104026, PP. 203-208

Keywords: 肥胖症，中药，肠道菌群，代谢产物，作用机制
Obesity, Traditional Chinese Medicine, Intestinal Flora, Metabolite, Metabolic Mechanism

Full-Text   Cite this paper   Add to My Lib

Abstract:

中医药因其疗效和预防作用促使其在治疗肥胖症方面有独特的优势，但其结构复杂、作用机制不明确等限制了其现代化、国际化和产业化的发展。肠道菌群与中药组分之间的相互作用在治疗过程中有着至关重要的作用。本文从肠道菌群影响肥胖症的分子机制出发，结合中药靶向肠道菌群治疗肥胖的疗效和作用机制，发现中药可调控肠道菌群结构、增加益生菌、降低致病菌等来抑制体质量增加、改善内毒素血症和胰岛素抵抗进一步达到预防肥胖等作用，同时肠道菌群又可促进中药化学成分的分解、提高生物利用性和生物活性、介导中药活性组分之间的拮抗和协同作用，分析了中药通过调控肠道菌群达到降脂减肥的研究进展，以期阐明中药、肠道菌群、肥胖三者之间的内在联系，为研发高效低毒的减肥中药提供研究思路。
Traditional Chinese medicine has unique advantages in the treatment of obesity due to its curative effect and preventive effect, but its complex structure and unclear mechanism of action limit its modernization, internationalization and industrialization. The interaction between intestinal flora and TCM components plays a vital role in the treatment process. In this paper, starting from the molecular mechanism of intestinal flora affecting obesity, combined with the curative effect and mechanism of traditional Chinese medicine targeting intestinal flora in the treatment of obesity, it is found that traditional Chinese medicine can regulate the structure of intestinal flora, increase probiotics and reduce pathogenic bacteria to inhibit weight gain, improve endotoxemia and insulin resistance to further prevent obesity. At the same time, intestinal flora can promote the decomposition of chemical components of traditional Chinese medicine, improve bioavailability and bioactivity, and mediate the antagonism and synergy between active components of traditional Chinese medicine. The research progress of traditional Chinese medicine through regulating intestinal flora to reduce obesity is analyzed, in order to clarify the internal relationship between traditional Chinese medicine, intestinal flora and obesity, and provide research ideas for the development of high efficiency and low toxicity traditional Chinese medicine.

References

[1]	Xiao, Q.Z., Zhu, L.J., Fu, Z.Y., et al. (2021) Obesity Related microRNA-424 Is Regulated by TNF-α in Adipocytes. Molecular Medicine Reports, 23, 21. https://doi.org/10.3892/mmr.2020.11659
[2]	Afshin, A., Forouzanfar, M.H., Reitsma, M.B., et al. (2017) Health Effects of Overweight and Obesity in 195 Countries over 25 Years. The New Eng-land Journal of Medicine, 377, 13-27. https://doi.org/10.1056/NEJMoa1614362
[3]	Tremaroli, V. and B？ckhed, F. (2012) Functional Interactions between the Gut Microbiota and Host Metabolism. Nature, 489, 242-249. https://doi.org/10.1038/nature11552
[4]	Cani, P.D., Possemiers, S., Van de Wiele, T., et al. (2009) Changes in Gut Microbiota Control Inflammation in Obese Mice through a Mechanism Involving GLP-2-Driven Improvement of Gut Permeability. Gut, 58, 1091-1103. https://doi.org/10.1136/gut.2008.165886
[5]	Guo, B., Xie, N. and Wang, Y. (2015) Cooperative Effect of Bifidobacteria Lipoteichoic Acid Combined with 5-Fluorouracil on Hepatoma-22 Cells Growth and Apoptosis. Bulletin du Cancer, 102, 204-212. https://doi.org/10.1016/j.bulcan.2014.09.003
[6]	Engevik, M.A., Luk, B., Chang-Graham, A.L., et al. (2019) Bifidobacterium Dentium Fortifies the Intestinal Mucus Layer via Autophagy and Calcium Signaling Pathways. mBio, 10, e01087-19. https://doi.org/10.1128/mBio.01087-19
[7]	Xu, J., Chen, H.B. and Li, S.L. (2016) Understanding the Molecular Mechanisms of the Interplay between Herbal Medicines and Gut Microbiota. Medicinal Research Reviews, 37, 1140-1185. https://doi.org/10.1002/med.21431
[8]	汤齐, 高霞, 耿婷, 等. 肠道菌群与中药相互作用的研究进展[J]. 中草药, 2017, 48(17): 3629-3635.
[9]	Qin, J., Li, R., Raes, J., et al. (2010) A Human Gut Microbial Gene Catalogue Established by Metagenomic Sequencing. Nature, 464, 59-65. https://doi.org/10.1038/nature08821
[10]	Zhang, C.H., Zhang, M.H., Wang, S.Y., et al. (2010) Interactions be-tween Gut Microbiota, Host Genetics and Diet Relevant to Development of Metabolic Syndromes in Mice. The Interna-tional Society for Microbial Ecology Journal, 4, 232-241. https://doi.org/10.1038/ismej.2009.112
[11]	Huo, Y., Lu, X.H., Wang, X.Y., et al. (2020) Bifidobacterium animalis subsp. lactis A6 Alleviates Obesity Associated with Promot-ing Mitochondrial Biogenesis and Function of Adipose Tissue in Mice. Molecules, 25, 1490. https://doi.org/10.3390/molecules25071490
[12]	Nicholson, J.K., Holmes, L., et al. (2012) Host-Gut Microbiota Metabolic Interactions. Science, 336, 1262-1267. https://doi.org/10.1126/science.1223813
[13]	Belizário, J.E., Faintuch, J. and Garay-Malpartida, M. (2018) Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases. Mediators of In-flammation, 2018, Article ID: 2037838. https://doi.org/10.1155/2018/2037838
[14]	Henning, S.M., Yang, J.P., Hsu, M., et al. (2018) Decaffeinated Green and Black Tea Polyphenols Decrease Weight Gain and Alter Microbiome Populations and Function in Diet-Induced Obese Mice. European Journal of Nutrition, 57, 2759-2769. https://doi.org/10.1007/s00394-017-1542-8
[15]	Sham, H.P., Bazett, M., Bosiljcic, M., et al. (2018) Immune Stim-ulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ul-cerative Colitis. Frontiers in Immunology, 9, 2211. https://doi.org/10.3389/fimmu.2018.02211
[16]	傅春妮, 周磊, 王欢欢, 等. 富硒乳酸菌对小鼠生长、血液生化指标、肠道菌群和细胞因子的影响[J]. 天津农学院学报, 2020, 27(3): 49-52.
[17]	Liu, R., Hong, J., Xu, X., et al. (2017) Gut Microbiome and Serum Metabolome Alterations in Obesity and after Weight-Loss Intervention. Nature Med-icine, 23, 859-868. https://doi.org/10.1038/nm.4358
[18]	Salden, B.N., Troost, F.J., Wilms, E., et al. (2018) Rein-forcement of Intestinal Epithelial Barrier by Arabinoxylans in Overweight and Obese Subjects: A Randomized Controlled Trial: Arabinoxylans in Gut Barrier. Clinical Nutrition, 37, 471-480. https://doi.org/10.1016/j.clnu.2017.01.024
[19]	Freitas, M., Axelsson, L.G., Cayuela, C., et al. (2002) Microbi-al-Host Interactions Specifically Control the Glycosylation Pattern in Intestinal Mouse Mucosa. Histochemistry and Cell Biology, 118, 149-161. https://doi.org/10.1007/s00418-002-0432-0
[20]	Petra, A.I., Panagiotidou, S., Hatziagelaki, E., et al. (2015) Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders with Suspected Immune Dysregulation. Clinical Therapeutics, 37, 984-995. https://doi.org/10.1016/j.clinthera.2015.04.002
[21]	van de Wouw, M., Schellekens, H., Dinan, T.G., et al. (2017) Microbiota-Gut-Brain Axis: Modulator of Host Metabolism and Appetite. The Journal of Nutrition, 147, 727-745. https://doi.org/10.3945/jn.116.240481
[22]	Lin, R., He, X., Chen, H., et al. (2018) Oil Tea Improves Glucose and Lipid Levels and Alters Gut Microbiota in Type 2 Diabetic Mice. Nutrition Research, 57, 67-77. https://doi.org/10.1016/j.nutres.2018.05.004
[23]	Mei, X., Zhang, X., Wang, Z., et al. (2016) Insulin Sensitivi-ty-Enhancing Activity of Phlorizin Is Associated with Lipopolysaccharide Decrease and Gut Microbiota Changes in Obese and Type 2 Diabetes Mice. Journal of Agricultural and Food Chemistry, 64, 7502-7511. https://doi.org/10.1021/acs.jafc.6b03474
[24]	Porras, D., Nistal, E., Martníez-Flórez, S., et al. (2017) Protective Effect of Quercetin on High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice Is Mediated by Modulating Intestinal Microbiota Imbalance and Related Gut-Liver Axis Activation. Free Radical Biology and Medicine, 102, 188-202. https://doi.org/10.1016/j.freeradbiomed.2016.11.037
[25]	Canfora, E.E., Meex, R.C.R., Venema, K., et al. (2019) Gut Microbial Metabolites in Obesity, NAFLD and T2DM. Nature Reviews Endocrinology, 15, 261-273. https://doi.org/10.1038/s41574-019-0156-z
[26]	Zhang, X., Zhao, Y., Xu, J., et al. (2015) Modulation of Gut Mi-crobiota by Berberine and Metformin during the Treatment of High-Fat Diet-Induced Obesity in Rats. Scientific Reports, 5, Article No. 14405. https://doi.org/10.1038/srep14405
[27]	Guo, C., Han, L., Li, M. and Yu, L. (2020) Seabuckthorn (Hippopha？ rhamnoides) Freeze-Dried Powder Protects against High-Fat Diet-Induced Obesity, Lipid Metabolism Disorders by Modulating the Gut Microbiota of Mice. Nutrients, 12, 265. https://doi.org/10.3390/nu12010265
[28]	Zhang, Y.J., Zheng, X.J., Huang, F.J., et al. (2019) Ursodeoxycholic Acid Alters Bile Acid and Fatty Acid Profiles in a Mouse Model of Diet-Induced Obesity. Frontiers in Pharmacology, 10, 842. https://doi.org/10.3389/fphar.2019.00842
[29]	An, Y., Li, Y., Wang, X., et al. (2018) Cordycepin Reduces Weight through Regulating Gut Microbiota in High-Fat Di-et-Induced Obese Rats. Lipids in Health and Disease, 17, 276. https://doi.org/10.1186/s12944-018-0910-6
[30]	Li, C., Zhang, H. and Li, X. (2020) The Mechanism of Traditional Chinese Medicine for the Treatment of Obesity. Diabetes Metabolic Syndrome and Obesity, 13, 3371-3381. https://doi.org/10.2147/DMSO.S274534
[31]	Chang, C.J., Lin, C.S., et al. (2015) Ganoderma lucidum Reduces Obesity in Mice by Modulating the Composition of the Gut Microbiota. Nature Communications, 6, 7489. https://doi.org/10.1038/ncomms8489
[32]	桑婷婷, 郭铖洁, 郭丹丹, 等. 中医药通过调节肠道菌群抑制肥胖和炎症相关疾病的进展研究[J]. 中国中药杂志, 2018, 43(16): 3235-3242.

Full-Text